Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
94.56
-0.94 (-0.98%)
At close: Aug 8, 2025, 4:00 PM
94.73
+0.17 (0.18%)
After-hours: Aug 8, 2025, 7:44 PM EDT
Illumina Employees
Illumina had 10,370 employees as of December 31, 2024. The number of employees decreased by 2,020 or -16.30% compared to the previous year.
Employees
10,370
Change (1Y)
-2,020
Growth (1Y)
-16.30%
Revenue / Employee
$413,115
Profits / Employee
$121,215
Market Cap
14.53B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
Dec 31, 2023 | 12,390 | -970 | -7.26% |
Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
Dec 29, 2019 | 7,700 | 400 | 5.48% |
Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
Dec 31, 2017 | 6,200 | 700 | 12.73% |
Dec 31, 2016 | 5,500 | 900 | 19.57% |
Dec 31, 2015 | 4,600 | 900 | 24.32% |
Dec 28, 2014 | 3,700 | 700 | 23.33% |
Dec 29, 2013 | 3,000 | 800 | 36.36% |
Dec 31, 2012 | 2,200 | -200 | -8.33% |
Dec 30, 2012 | 2,400 | 300 | 14.29% |
Dec 31, 2011 | 2,100 | 319 | 17.91% |
Dec 31, 2010 | 1,781 | 245 | 15.95% |
Dec 28, 2008 | 1,536 | 495 | 47.55% |
Dec 30, 2007 | 1,041 | 445 | 74.66% |
Dec 31, 2006 | 596 | 221 | 58.93% |
Dec 31, 2005 | 375 | 97 | 34.89% |
Dec 31, 2004 | 278 | 42 | 17.80% |
Dec 28, 2003 | 236 | 3 | 1.29% |
Dec 29, 2002 | 233 | 54 | 30.17% |
Dec 30, 2001 | 179 | 74 | 70.48% |
Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ILMN News
- 6 days ago - Illumina: The Stock Is Still Undervalued - Seeking Alpha
- 9 days ago - These Analysts Boost Their Forecasts On Illumina Following Upbeat Results - Benzinga
- 9 days ago - Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 - PRNewsWire
- 11 days ago - Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling - PRNewsWire
- 24 days ago - Illumina Stock: What Went Wrong And Why It's Best To Stay Away - Benzinga
- 4 weeks ago - Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds - Seeking Alpha
- 4 weeks ago - Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 - PRNewsWire